PALO ALTO, CALIFORNIA / ACCESSWIRE / January 14, 2025 / Bioz, Inc., a leader in AI-driven citation management and product engagement, is proud to celebrate its ongoing partnership with Chondrex, a collaboration that continues to drive innovation and elevate scientific discovery. Through the integration of Bioz Badges, Chondrex has experienced strong product visibility and excellent customer engagement, empowering researchers with real-world evidence of product applications.
Chondrex currently leverages Bioz Badges, which integrate detailed citation data onto Chondrex’s website, to showcase the scientific credibility and real-world applications of their products. These badges dynamically display references from peer-reviewed and preprint publications, allowing researchers to see how Chondrex’s products are being utilized in diverse research experiments. By providing a comprehensive view of published data, Bioz Badges help researchers explore the versatility of Chondrex’s offerings, whether in inflammation studies, autoimmune disease models, and allergy research. This evidence-based approach not only establishes trust but also empowers researchers to make informed decisions by highlighting practical applications, successful methodologies, and relevant outcomes associated with Chondrex’s products across various disciplines.
Building on the success of their initial implementation of Bioz Badges, Chondrex recently upgraded to Bioz Pro Badges, introducing enhanced capabilities to their website. The Pro package unlocks additional features such as dynamic citation filtering and advanced analytics. This upgrade allows Chondrex to provide researchers with an even more seamless experience while gaining deeper insights into customer engagement.
Takaki Waritani, Chondrex’s President, expressed his enthusiasm for the partnership: “Bioz Badges have been instrumental in helping us showcase the multifunctionality of our products and the broad scope of their applications. Our customers are now able to see clear, evidence-backed data right on our website, which has significantly enhanced their decision-making experience and has built strong trust in our offerings. The detailed metrics provided by Bioz also help us to make data-driven decisions to optimize our outreach.”
“Chondrex’s success is a testament to how AI-powered tools such as Bioz Badges can transform product selection decision-making and customer satisfaction,” said Dr. Karin Lachmi, Chief Revenue Officer and Co-Founder of Bioz. “The metrics they’ve achieved so far are impressive, and we’re looking forward to seeing even greater results.”
Bioz’s partnership with Chondrex continues to set the standard for how advanced AI tools can support scientific suppliers in enhancing customer experience, increasing sales, and driving impactful research outcomes.
About Bioz
Bioz is the world’s most advanced AI search engine for scientific research, offering evidence-based product ratings and recommendations to guide scientists toward the most validated products for their discoveries. Bioz’s solutions for suppliers include Bioz Badges and Content Hubs, web-based widgets that enhance user engagement and increase sales conversion.
About Chondrex
Chondrex, Inc. provides high-quality, specialized products for inflammation, autoimmune disease, and allergy research. Trusted by researchers worldwide, Chondrex offers a comprehensive portfolio of tools designed to accelerate scientific discovery. Their innovative products support a wide range of applications, from basic research to translational and clinical studies, making Chondrex a leader in the life sciences industry.
Helpful Links
For more information on Bioz solutions for suppliers, please reach out to info@bioz.com.
Contact Information
Daniel Levitt
CEO
pr@bioz.com
SOURCE: Bioz, Inc.
View the original press release on accesswire.com
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapySAN…
Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…
Olympus to sell and distribute its medical technologies directly in Chile and extend its medical…
PITTSBURGH, Jan. 14, 2025 /PRNewswire/ -- Today, Apollo Neuroscience is proud and honored to announce our latest…